Featured Research

from universities, journals, and other organizations

Pinpoint Targeting Promises Improved Success In Gene Therapy

Date:
August 18, 1999
Source:
University Of North Carolina At Chapel Hill
Summary:
Research on a rare inherited blood disorder known as Glanzmann's disease shows for the first time that it's possible to target specific types of cells during gene therapy and avoid the less effective -- and possibly more dangerous -- "shotgun" approach now used, according to a new University of North Carolina at Chapel Hill School of Medicine study.

CHAPEL HILL - Research on a rare inherited blood disorder known as Glanzmann's disease shows for the first time that it's possible to target specific types of cells during gene therapy and avoid the less effective -- and possibly more dangerous -- "shotgun" approach now used, according to a new University of North Carolina at Chapel Hill School of Medicine study.

With more work, the method could help treat a host of gene-related illnesses including various cancers, UNC-CH scientists say.

"Using techniques first developed by other investigators, we created a way of targeting the expression, or production, of genetic material in blood platelets without affecting red or white blood cells at the same time," said Dr. Gilbert C. White II, professor of medicine and director of UNC-CH's Center for Thrombosis and Hemostasis. "This offers great promise for improved treatment of inherited blood disorders such as hemophilia and conceptual support for using the approach for non-inherited illnesses such as cancer.

"For example, if you wanted to get poison genes into cancer cells but not into other healthy cells, one could attach the poison gene to specific promoters -- or pieces of DNA - that function only in cancer cells and not in others."

A report on the study appears in the Aug. 17 issue of the Proceedings of the National Academy of Sciences. Besides White, authors are Drs. David A. Wilcox, a former UNC-CH postdoctoral fellow now at the Medical College of Wisconsin; John C. Olsen, research assistant professor of medicine at UNC-CH; and Lori Ishizawa and Michael Griffith of Nexell Therapeutics Inc. of Irvine, Calif.

Wilcox said he and his colleagues concentrated on correcting primitive stem cells - sometimes considered "parent" cells -- capable of developing into more specialized large cells. Those younger monster cells, called megakaryocytes, form in bone marrow and eventually shatter into at least hundreds of particles that become blood platelets. The body uses platelets, which float around in the bloodstream, to plug wound sites to stop bleeding and heal cuts and other wounds.

The scientists focused on Glanzmann's disease - which, because of a missing protein, prevents platelets from functioning properly -- as a model system for their work. In the laboratory, they succeeded in correcting the protein defect in the parent cells by inserting healthy genes into DNA with the help of a harmless virus that penetrated the cell walls.

"This work is novel to gene therapy because the method successfully uses a promoter that targets a protein that was missing or defective in megakaryocytes and not in other cell types," Wilcox said. Conceivably, all sorts of healthy replacement genes or even drugs could be attached to identical or similar promoters and function as well as they did in platelets but without affecting unrelated cells and cell functions, he said. Extensive testing of "daughter" cells such as red cells and white cells confirmed the method worked only where it was supposed to. There was no potentially hazardous effect on other cells.

"We target the parent stem cells because we want the therapy to last for a long time in humans," Wilcox said. "That wouldn't be possible if we just targeted platelets since a platelet's life span in the bloodstream averages only 21 days."

Wilcox, who called the findings "exciting and potentially very important," said more advanced studies already are under way at UNC-CH. Mouse and human cell experiments, while still in preliminary stages, have progressed well so far, he said.


Story Source:

The above story is based on materials provided by University Of North Carolina At Chapel Hill. Note: Materials may be edited for content and length.


Cite This Page:

University Of North Carolina At Chapel Hill. "Pinpoint Targeting Promises Improved Success In Gene Therapy." ScienceDaily. ScienceDaily, 18 August 1999. <www.sciencedaily.com/releases/1999/08/990818071552.htm>.
University Of North Carolina At Chapel Hill. (1999, August 18). Pinpoint Targeting Promises Improved Success In Gene Therapy. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/1999/08/990818071552.htm
University Of North Carolina At Chapel Hill. "Pinpoint Targeting Promises Improved Success In Gene Therapy." ScienceDaily. www.sciencedaily.com/releases/1999/08/990818071552.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins